Page last updated: 2024-09-03

probestin and Lymphoma, T-Cell

probestin has been researched along with Lymphoma, T-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ansorge, S; Arndt, M; Frank, K; Kähne, T; Lendeckel, U	1

Other Studies

1 other study(ies) available for probestin and Lymphoma, T-Cell

Article	Year
Inhibition of alanyl aminopeptidase induces MAP-kinase p42/ERK2 in the human T cell line KARPAS-299. Biochemical and biophysical research communications, 1998, Nov-09, Volume: 252, Issue:1 Topics: Calcium-Calmodulin-Dependent Protein Kinases; CD13 Antigens; Cell Line; Enzyme Induction; Gene Expression Regulation, Enzymologic; Humans; Hydroxamic Acids; Lymphoma, T-Cell; Mitogen-Activated Protein Kinase 1; Oligopeptides; Phosphorylation; Polymerase Chain Reaction; Protease Inhibitors; RNA, Messenger; T-Lymphocytes; Transcription, Genetic; Tumor Cells, Cultured	1998

Article

Year

Inhibition of alanyl aminopeptidase induces MAP-kinase p42/ERK2 in the human T cell line KARPAS-299.

Biochemical and biophysical research communications, 1998, Nov-09, Volume: 252, Issue:1

Topics: Calcium-Calmodulin-Dependent Protein Kinases; CD13 Antigens; Cell Line; Enzyme Induction; Gene Expression Regulation, Enzymologic; Humans; Hydroxamic Acids; Lymphoma, T-Cell; Mitogen-Activated Protein Kinase 1; Oligopeptides; Phosphorylation; Polymerase Chain Reaction; Protease Inhibitors; RNA, Messenger; T-Lymphocytes; Transcription, Genetic; Tumor Cells, Cultured

1998